Bone Mineral Density in Older HIV Adults Switching to Triumeq

Phase 4, open-label, single-arm trial of abacavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Mills Clinical Research. Primary endpoints: Percent change from Baseline at Week 48 in total hip Bone Mineral Density and Percent change from Baseline at Week 48 in lumbar spine Bone Mineral Density. Status: unknown.